Amgen

Amgen ramps up Otezla expansion effort with positive data in mild psoriasis
Fierce Pharma
Thu, 05/7/20 - 12:27 am
Amgen
Celgene
Otezla
psoriasis
Here’s how some big U.S. drugmakers expect Covid-19 to affect them this year
MedCity News
Mon, 05/4/20 - 10:37 pm
COVID-19
pandemic
Gilead Sciences
Pfizer
Eli Lilly
JNJ
Merck
Amgen
Amgen to test psoriasis pill Otezla in COVID-19
Pharmaforum
Sun, 05/3/20 - 07:54 pm
Amgen
Otezla
clinical trials
COVID-19
Amgen's anti-inflammatory Otezla makes its foray into COVID-19
Fierce Pharma
Fri, 05/1/20 - 12:47 pm
Amgen
Celgene
Otezla
M&A
COVID-19
Biotech company Amgen expanding its Tampa operations hub
Tampa Bay Times
Fri, 04/24/20 - 11:02 am
Amgen
Florida
expansion
Tampa
Amgen teams up with Adaptive to both treat and prevent COVID-19
Fierce Biotech
Thu, 04/2/20 - 10:56 am
Amgen
Adaptive Biotechnologies
R&D
COVID-19
Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug
Fierce Biotech
Tue, 03/31/20 - 10:54 am
Amgen
KRAS
AMG 510
COVID-19
clinical trials
cancer
ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients
Fierce Pharma
Sat, 03/28/20 - 11:30 pm
ACC
Repatha
HIV
clinical trials
Amgen
Drug makers grounding salespeople as coronavirus impact on business spreads
Stat
Mon, 03/16/20 - 10:45 am
Amarin
Amgen
Merck
drug reps
coronaviruses
COVID-19
Amgen/Allergan’s rituximab biosimilar could be $4bn blockbuster
Pharmaforum
Wed, 03/11/20 - 10:45 am
Amgen
Allergan
biosimilars
Roche
rituximab
10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says
BioSpace
Mon, 03/9/20 - 11:10 pm
biosimilars
Amgen
Allergan
Roche
Rituxan
Bristol-Myers Squibb
ozanimod
risdiplam
Biomarin
valrox
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Fierce Pharma
Fri, 03/6/20 - 11:27 pm
COVID-19
coronaviruses
Roche
GSK
Bristol-Myers Squibb
Sanofi
Boehringer Ingelheim
Amgen
Biogen
Mylan
Pfizer, Amgen, Lilly spent most to lobby Congress, study finds
BioPharma Dive
Wed, 03/4/20 - 08:02 pm
pharma industry
lobbying
Pfizer
Amgen
Eli Lilly
Trial of Amgen, Servier’s heart failure drug clears interim check
PM Live
Fri, 02/28/20 - 10:18 am
Amgen
Servier
chronic heart failure
Omecamtiv Mecarbil
clinical trials
Amgen heart drug passes interim check, setting up year-end readout
BioPharma Dive
Wed, 02/26/20 - 11:24 pm
Amgen
Omecamtiv Mecarbil
Cytokinetics
If biotech had a Mount Rushmore, whose heads would you chisel in the granite?
Stat
Tue, 02/4/20 - 10:04 am
biotech
Jeff Leiden
Vertex Pharmaceuticals
Herb Boyer
Bob Swanson
Genentech
Amgen
George Rathmann
Gordon Binder
Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors?
Motley Fool
Sun, 02/2/20 - 11:54 pm
Amgen
earnings
M&A
Asia
Amgen, Pfizer biosimilar sales pressure top drugs
BioPharma Dive
Fri, 01/31/20 - 12:13 pm
biosimilars
Amgen
Pfizer
Roche
Amgen Revenue Slipped 1% in the Fourth Quarter
Motley Fool
Thu, 01/30/20 - 09:25 pm
Amgen
earnings
Big pharma backed away from brain drugs. Is a return in sight?
BioPharma Dive
Wed, 01/29/20 - 11:55 pm
Big Pharma
Neuroscience
AstraZeneca
Bristol-Myers Squibb
GSK
Pfizer
Amgen

Pages